...
首页> 外文期刊>Archives of Toxicology >New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
【24h】

New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.

机译:单次口服氘标记的DEHP后,人尿液和血清中邻苯二甲酸二(2-乙基己基)酯(DEHP)的新代谢产物。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The metabolism of di(2-ethylhexyl)phthalate (DEHP) in humans was studied after three doses of 0.35 mg (4.7 microg/kg), 2.15 mg (28.7 microg/kg) and 48.5 mg (650 microg/kg) of D4-ring-labelled DEHP were administered orally to a male volunteer. Two new metabolites, mono(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and mono[2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) were monitored for 44 h in urine and for 8 h in serum for the high-dose case, in addition to the three metabolites previously analysed: mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP), mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and mono(2-ethylhexyl)phthalate (MEHP). For the medium- and low-dose cases, 24 h urine samples were analysed. Up to 12 h after the dose, 5OH-MEHP was the major urinary metabolite, after 12 h it was 5cx-MEPP, and after 24 h it was 2cx-MMHP. The elimination half-lives of 5cx-MEHP and 2cx-MMHP were between 15 and 24 h. After 24 h 67.0% (range: 65.8-70.5%) of the DEHP dose was excreted in urine, comprising 5OH-MEHP (23.3%), 5cx-MEPP (18.5%), 5oxo-MEHP (15.0%), MEHP (5.9%) and 2cx-MMHP (4.2%). An additional 3.8% of the DEHP dose was excreted on the second day, comprising 2cx-MMHP (1.6%), 5cx-MEPP (1.2%), 5OH-MEHP (0.6%) and 5oxo-MEHP (0.4%). In total about 75% of the administered DEHP dose was excreted in urine after two days. Therefore, in contrast to previous studies, most of the orally administered DEHP is systemically absorbed and excreted in urine. No dose dependency in metabolism and excretion was observed. The secondary metabolites of DEHP are superior biomonitoring markers compared to any other parameters, such as MEHP in urine or blood. 5OH-MEHP and 5oxo-MEHP in urine reflect short-term and 5cx-MEHP and 2cx-MMHP long-term exposure. All secondary metabolites are unsusceptible to contamination. Furthermore, there are strong hints that the secondary oxidised DEHP metabolites-not DEHP or MEHP-are the ultimate developmental toxicants.
机译:研究了三剂0.35 mg(4.7 microg / kg),2.15 mg(28.7 microg / kg)和48.5 mg(650 microg / kg)D4-的三剂后人体中邻苯二甲酸二(2-乙基己基)酯(DEHP)的代谢环标记的DEHP口服给男性志愿者。监测了两种新的代谢产物,邻苯二甲酸单(2-乙基-5-羧基戊基)酯(5cx-MEPP)和邻苯二甲酸单[2-(羧甲基)己基]邻苯二甲酸酯(2cx-MMHP),在尿液中监测了44小时,在血清中监测了8小时。大剂量的情况下,除了先前分析的三种代谢物:邻苯二甲酸单(2-乙基-5-羟基己基)(5OH-MEHP),邻苯二甲酸单(2-乙基-5-氧己基)(5oxo-MEHP)和邻苯二甲酸(2-乙基己基)酯(MEHP)。对于中,低剂量病例,分析了24小时尿液样本。给药后最多12小时,5OH-MEHP是主要的尿代谢产物,12小时后为5cx-MEPP,24小时后为2cx-MMHP。 5cx-MEHP和2cx-MMHP的消除半衰期在15至24小时之间。 24小时后,尿中排出了DEHP剂量的67.0%(范围:65.8-70.5%),其中包括5OH-MEHP(23.3%),5cx-MEPP(18.5%),5oxo-MEHP(15.0%),MEHP(5.9 %)和2cx-MMHP(4.2%)。第二天再排泄DEHP剂量的3.8%,其中包括2cx-MMHP(1.6%),5cx-MEPP(1.2%),5OH-MEHP(0.6%)和5oxo-MEHP(0.4%)。两天后,总共约有75%的DEHP剂量从尿液中排出。因此,与以前的研究相反,大多数口服DEHP会被尿液全身吸收和排泄。没有观察到新陈代谢和排泄的剂量依赖性。与任何其他参数(例如尿液或血液中的MEHP)相比,DEHP的次生代谢产物是优异的生物监测标记。尿液中的5OH-MEHP和5oxo-MEHP反映了短期和5cx-MEHP和2cx-MMHP的长期暴露。所有次级代谢产物均不易受到污染。此外,有强烈的暗示是,次级氧化的DEHP代谢物而不是DEHP或MEHP是最终的发育毒物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号